2023年5月31日

美国大麻涉众组再次批评政府的食品和药物管理局(FDA)得出结论基于过时的研究夸大了CBD的潜在危险。昨天在一封信中,参议院和众议院委员会,美国麻圆桌会议(USHR)抨击根据研究机构高度集中药学班CBD配方的基础上,而忽略自2020年以来,最近的研究表明低剂量的处方提取是安全的。德赢 win官网消费者永远不会被暴露在大量的CBD研究FDA所引用,USHR说,“即使是必不可少的营养成分如维生素D可以是有益的和有毒取决于剂量。“分心”随着国会的发展计划,以确保麻提取物如CBD的规定,应该关注的这些产品通常是如何使用的,而不是被研究,想象他们的过度消费总值不是一个现实的问题,”USHR总法律顾问乔纳森•米勒在信中写道,送到参议院健康委员会,教育,就业和养老金,和众议院能源和商业委员会。“结合低数量的不良事件与CBD相关产品和现实世界,观测数据还指出,CBD的安全,证据的整体描绘了一幅不同的画面比FDA提出的,”米勒写道。现行规则足够吗?批评遵循FDA发布的3月一本40页的“审查的口服毒性大麻二酚(CBD)“基于编译现有的临床研究。本文提出一系列的问题,尤其是关于CBD的潜在有害影响的儿童,孕妇和胎儿,老人。作者总结长期食用CBD需要进一步的研究。FDA重复观测在上周举行的一次研讨会。 FDA declared in January that it is unable to set rules for CBD until Congress acts to clearly legalize such products, after nearly five years during which stakeholders repeatedly called for the establishment of a regulatory framework following the legalization of hemp and its downstream derivatives as a result of the 2018 Farm Bill. In this week’s letter, USHR repeated its long-held position that the existing regulatory framework for foods and supplements – which includes mandatory good manufacturing practices, dietary ingredient notification requirements, and obligatory serious adverse event reporting – is sufficient to ensure over-the-counter CBD products are safe. Down the drug pathway? Some close observers of the sector have theorized that the FDA may be about to wall off CBD as a prescription-only drug . That wouldn’t necessarily be surprising. First of all, because of the proliferation of low-quality products – fanned by bogus health claims – represents immediate health risks. More ominously, because FDA has insisted that long-term research on over-the-counter CBD is still needed, there does not appear to be a fast way to ensure its safety. The agency has already approved one medical-grade CBD product, indicating drug designation as an obvious pathway – one which would essentially wipe out most operators now on the market. Like HempToday? How you can support us Your donations help us to keep HempToday open for all readers, regardless of what they can afford to pay. Through this “information equality” we're able to support hemp entrepreneurs and stakeholders all over the world by keeping a spotlight on hemp and all the promise it offers for economic development and healing our planet. Get Hemp Industry Updates